Fredag 2 Oktober | 12:53:23 Europe / Stockholm
Est. tid*
2026-11-06 08:30 Kvartalsrapport 2026-Q3
2026-08-21 - Kvartalsrapport 2026-Q2
2026-05-15 - Kvartalsrapport 2026-Q1
2026-05-11 - X-dag ordinarie utdelning NOSA 0.00 SEK
2026-05-08 - Årsstämma
2026-02-13 - Bokslutskommuniké 2025
2025-11-07 - Kvartalsrapport 2025-Q3
2025-10-23 - Extra Bolagsstämma 2025
2025-08-22 - Kvartalsrapport 2025-Q2
2025-05-15 - Kvartalsrapport 2025-Q1
2025-05-12 - X-dag ordinarie utdelning NOSA 0.00 SEK
2025-05-09 - Årsstämma
2025-02-14 - Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-05-10 - Kvartalsrapport 2024-Q1
2024-05-06 - X-dag ordinarie utdelning NOSA 0.00 SEK
2024-05-03 - Årsstämma
2024-02-16 - Bokslutskommuniké 2023
2023-12-27 - Extra Bolagsstämma 2023
2023-11-10 - Kvartalsrapport 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-12 - Kvartalsrapport 2023-Q1
2023-03-13 - X-dag ordinarie utdelning NOSA 0.00 SEK
2023-03-10 - Årsstämma
2023-02-16 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-10-31 - Extra Bolagsstämma 2022
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-12 - Kvartalsrapport 2022-Q1
2022-04-22 - X-dag ordinarie utdelning NOSA 0.00 SEK
2022-04-21 - Årsstämma
2022-03-02 - Bokslutskommuniké 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-07-15 - Kvartalsrapport 2021-Q2
2021-04-29 - Kvartalsrapport 2021-Q1
2021-03-01 - X-dag ordinarie utdelning NOSA 0.00 SEK
2021-02-26 - Årsstämma
2021-02-25 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-11-04 - Extra Bolagsstämma 2020
2020-08-27 - Kvartalsrapport 2020-Q2
2020-05-07 - Kvartalsrapport 2020-Q1
2020-03-27 - X-dag ordinarie utdelning NOSA 0.00 SEK
2020-03-26 - Årsstämma
2020-01-30 - Extra Bolagsstämma 2019
2020-01-27 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-06-04 - Årsstämma
2019-05-17 - X-dag ordinarie utdelning NOSA 0.00 SEK
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-21 - Bokslutskommuniké 2018
2018-11-07 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-05-17 - Årsstämma
2018-05-09 - Kvartalsrapport 2018-Q1
2018-05-03 - X-dag ordinarie utdelning NOSA 0.00 SEK
2018-02-22 - Bokslutskommuniké 2017
2017-11-15 - Kvartalsrapport 2017-Q3
2017-08-30 - Kvartalsrapport 2017-Q2
2017-05-17 - Kvartalsrapport 2017-Q1
2017-05-04 - X-dag ordinarie utdelning NOSA 0.00 SEK
2017-05-03 - Årsstämma
2017-02-24 - Bokslutskommuniké 2016
2016-11-17 - Kvartalsrapport 2016-Q3
LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Nosa Plugs är verksamt inom medicinteknik. Bolaget är en utvecklare av intranasala andningsprodukter. Produktutbudet är brett och inkluderar exempelvis luktskydd, näsfilter mot luftburna allergener samt nässkydd som används för att reducera virus och bakterier. Produkterna används exempelvis av personer som lider av olika allergier. Störst verksamhet återfinns inom den nordiska marknaden, med huvudkontor i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

NOSA signs agreement with distributor in Morocco

2026-09-23 09:30:00

Nosa Plugs AB (“NOSA” or the “Company”) has entered into an exclusive distribution agreement with the Moroccan pharmaceutical company POLYMEDIC Co., Ltd (“Polymedic”) for the sale of Nozoil Original and Nozoil Menthol in the Moroccan market. The partnership provides NOSA with access to Polymedic’s nationwide distribution network. The launch is expected to take place following completion of the local registration process, which has been initiated and is currently estimated to take approximately 2–4 months. In connection with the launch, Polymedic is expected to place an initial order valued at approximately SEK 500,000.

The partnership is part of NOSA’s strategy to accelerate the international expansion of Nozoil through established local partners with an existing market presence and infrastructure. The launch in Morocco represents another step in the Company’s expansion in the MENA region and follows the agreement with MetroMed, which was signed earlier in the quarter.

Polymedic is an established Moroccan pharmaceutical company headquartered in Casablanca. The company manufactures and distributes pharmaceuticals and medical devices across several therapeutic areas and has approximately 260 employees. Its operations cover the entire Moroccan market.

Under the agreement, Polymedic will be responsible for the local commercialization and distribution of Nozoil Original and Nozoil Menthol in Morocco. The products will be distributed through Polymedic’s established relationships with national wholesalers, which in turn supply pharmacies and healthcare facilities throughout the country.

“Morocco is a new and interesting market for Nozoil, and Polymedic provides us with immediate access to an established commercial infrastructure. They have nationwide distribution, their own medical sales force, and established relationships across the pharmacy and hospital markets. Outside our core markets, this is exactly the type of partner we are looking for,” says Adrian Liljefors, CEO of Nosa Plugs AB.